Literature DB >> 6275823

Multiplicity activation of herpes simplex virus in mouse neuroblastoma (C1300) cells.

A Vahlne, E Nilheden, B Svennerholm.   

Abstract

The virus yields and number of infectious centres of HSV infected mouse neuroblastoma C1300 cells (clone 41 A3) infected at different multiplicities of infection (MOI) were found to vary more than the differences of HSV concentrations of the virus suspensions used for infection of the cells. This suggested that a C1300 cell had to be infected with more than one HSV particle in order to produce progeny virus-multiplicity activation. The greater than expected enhancement of virus production of C1300 cell cultures receiving increasing MOI of HSV was probably not due to improved virus adsorption, nor influenced by non-virus factors in the virus inoculum stimulatory for HSV replication. A hypothesis, that the block in virus replication was promoted by an inhibitor of an HSV specified regulatory protein and could be overcome by the addition of HSV DNA copies in the infected cell, was by the results of two types of experiments. Presence of phosphonoformic acid, an inhibitor of the HSV specified DNA polymerase, in the culture medium of HSV infected permissive GMK cells resulted in non-linear relationships between virus yields and MOI. An HSV temperature sensitive mutant (ts B5), defective in a late structural protein, rescued wild type HSV in C1300 cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275823     DOI: 10.1007/bf01320249

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  ABORTIVE INFECTION OF CANINE CELLS BY HERPES SIMPLEX VIRUS. II. ALTERNATIVE SUPPRESSION OF SYNTHESIS OF INTERFERON AND VIRAL CONSTITUENTS.

Authors:  L AURELIAN; B ROIZMAN
Journal:  J Mol Biol       Date:  1965-03       Impact factor: 5.469

2.  Acute infection of differentiated neuroblastoma cells by latency-positive and latency-negative herpes simplex virus ts mutants.

Authors:  J C Gerdes; H S Marsden; M L Cook; J G Stevens
Journal:  Virology       Date:  1979-04-30       Impact factor: 3.616

Review 3.  Latent herpes simplex virus and the nervous system,.

Authors:  J G Stevens
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

4.  Herpes simplex virus infection of mouse neuroblastoma cells (39880).

Authors:  A Vahlne; E Lycke
Journal:  Proc Soc Exp Biol Med       Date:  1977-10

5.  Herpes simplex virus infection of in vitro cultured neuronal cells (mouse neuroblastoma C 1300 cells).

Authors:  A Vahlne; E Lycke
Journal:  J Gen Virol       Date:  1978-05       Impact factor: 3.891

6.  Infection by herpes simplex virus and cells of nervous system origin: characterization of a non-permissive interaction.

Authors:  R Adler; J C Glorioso; M Levine
Journal:  J Gen Virol       Date:  1978-04       Impact factor: 3.891

Review 7.  Multiplicity reactivation of animal viruses.

Authors:  D G Sharp
Journal:  Prog Med Virol       Date:  1968

8.  Separation of herpes simplex virus virions and nucleocapsids on Percoll gradients.

Authors:  B Svennerholm; A Vahlne; S Jeansson; R Lundén; S Olofsson; G Svantesson; E Lycke
Journal:  J Virol Methods       Date:  1980       Impact factor: 2.014

9.  Subtyping of herpes simplex virus.

Authors:  A Vahlne; J Blomberg; S Olofsson; E Lycke
Journal:  Acta Pathol Microbiol Scand B       Date:  1975-10

10.  Persistence of herpes simplex virus genes in cells of neuronal origin.

Authors:  M Levine; A L Goldin; J C Glorioso
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

View more
  5 in total

1.  Amplification of herpes simplex virus resistance in mouse neuroblastoma (Cl300) cells.

Authors:  E Nilheden; S Jeansson; A Vahlne
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells.

Authors:  E Nilheden; S Jeansson; A Vahlne
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

3.  Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro.

Authors:  C L Wilcox; E M Johnson
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

4.  Inhibition of herpes simplex virus production in vitro by cyclosporin A.

Authors:  A Vahlne; P A Larsson; P Horal; J Ahlmén; B Svennerholm; J S Gronowitz; S Olofsson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Innate and adaptive immune responses to herpes simplex virus.

Authors:  Tracy Chew; Kathryne E Taylor; Karen L Mossman
Journal:  Viruses       Date:  2009-11-18       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.